A Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Generalized Refractory Myasthenia Gravis (GMG)

Administered By

Awarded By

Contributors

Start/End

  • January 15, 2014 - June 30, 2017